These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

508 related items for PubMed ID: 11567229

  • 1. MIB-1 (Ki-67), p53, estrogen receptor, and progesterone receptor expression in uterine smooth muscle tumors.
    Mittal K, Demopoulos RI.
    Hum Pathol; 2001 Sep; 32(9):984-7. PubMed ID: 11567229
    [Abstract] [Full Text] [Related]

  • 2. Expression of Ki-67, P53 and progesterone receptors in uterine smooth muscle tumors. Diagnostic value.
    Petrović D, Babić D, Forko JI, Martinac I.
    Coll Antropol; 2010 Mar; 34(1):93-7. PubMed ID: 20437637
    [Abstract] [Full Text] [Related]

  • 3. MIB-1 (Ki-67), estrogen receptor, progesterone receptor, and p53 expression in atypical cells in uterine symplastic leiomyomas.
    Sun X, Mittal K.
    Int J Gynecol Pathol; 2010 Jan; 29(1):51-4. PubMed ID: 19952937
    [Abstract] [Full Text] [Related]

  • 4. Ki-67 expression in patients with uterine leiomyomas, uterine smooth muscle tumors of uncertain malignant potential (STUMP) and uterine leiomyosarcomas (LMS).
    Mayerhofer K, Lozanov P, Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K.
    Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1085-8. PubMed ID: 15488127
    [Abstract] [Full Text] [Related]

  • 5. Leiomyosarcoma versus bizarre and cellular leiomyomas of the uterus: a comparative study based on the MIB-1 and proliferating cell nuclear antigen indices, p53 expression, DNA flow cytometry, and muscle specific actins.
    Amada S, Nakano H, Tsuneyoshi M.
    Int J Gynecol Pathol; 1995 Apr; 14(2):134-42. PubMed ID: 8601525
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Uterine leiomyosarcomas are characterized by high p16, p53 and MIB1 expression in comparison with usual leiomyomas, leiomyoma variants and smooth muscle tumours of uncertain malignant potential.
    O'Neill CJ, McBride HA, Connolly LE, McCluggage WG.
    Histopathology; 2007 Jun; 50(7):851-8. PubMed ID: 17543074
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Estrogen and progesterone receptor expression in patients with uterine smooth muscle tumors.
    Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Mayerhofer K.
    Fertil Steril; 2004 Apr; 81(4):1062-6. PubMed ID: 15066464
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Fascin expression in uterine smooth muscle tumors.
    Kefeli M, Yildiz L, Kaya FC, Aydin O, Kandemir B.
    Int J Gynecol Pathol; 2009 Jul; 28(4):328-33. PubMed ID: 19483633
    [Abstract] [Full Text] [Related]

  • 15. Atypical leiomyomas of the uterus with long-term follow-up after myomectomy with immunohistochemical analysis for p16INK4A, p53, Ki-67, estrogen receptors, and progesterone receptors.
    Sung CO, Ahn G, Song SY, Choi YL, Bae DS.
    Int J Gynecol Pathol; 2009 Nov; 28(6):529-34. PubMed ID: 19851199
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of chemokines CCL5 and CCL11 by smooth muscle tumor cells of the uterus and its possible role in the recruitment of mast cells.
    Zhu XQ, Lv JQ, Lin Y, Xiang M, Gao BH, Shi YF.
    Gynecol Oncol; 2007 Jun; 105(3):650-6. PubMed ID: 17368523
    [Abstract] [Full Text] [Related]

  • 19. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women.
    Baytur YB, Ozbilgin K, Cilaker S, Lacin S, Kurtul O, Oruc S, Koyuncu FM.
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256
    [Abstract] [Full Text] [Related]

  • 20. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner-Adler B, Bodner K, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K.
    J Soc Gynecol Investig; 2004 Apr; 11(3):182-6. PubMed ID: 15051038
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.